Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising ...

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and ...

New targeted drugs transform HER2, ROS1 and ALK lung cancer care, boosting brain response and survival—while precision choices still matter.

Researchers have developed RNA therapeutics, called micelles, that can delivery chemotherapeutic drugs to metastasized tumors in mouse models.

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses, physical ...

An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, have developed a new delivery system for inhalable mRNA vaccines. Published in ...

In a significant advancement for thoracic oncology within the Appalachian region, WVU Medicine has announced it is the first ...

From its first description in 1935 until now, clinical outcomes for patients with cystic fibrosis have undergone a dramatic transformation. While the rare genetic disease was once an early death ...

Engineering multifunctional extracellular vesicles that can selectively and effectively kill lung cancer cells with minimal off‑target toxicity, ...